Maykin Ho
Partner at Viridian Globa
New York, New York
Overview
Work Experience
Board Member
2021 - Current
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Raised $585,800,000.00.
Board Member
2019
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Raised $2,004,655,040.00 from CPP Investments, Huangpu River Capital, Illumina and PSP Investments.
Board Member
2018
FibroGen uses its expertise in CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Raised $308,023,000.00 from Hony Capital and AstraZeneca.
Board Member
2015
Viewpoint Datalabs is 3D digital content creation and publishing company.
Board Member
2015
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Raised $775,823,937.00 from Celgene, Flagship Pioneering, ARCH Venture Partners and Third Rock Ventures.
Venture Partner
2015
Partner
2015
Advisory Director, Healthcare Investment Banking
2010 - 2015
Healthcare Investment Banking in China and US
Partner, Senior Biotechnology Analyst
1992 - 2010
Partner and Co-head of Healthcare Research, Global Investment Research (2002-2010) Head of Biotechnology Investment Research (1992-2010)
Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.
Director, Strategic Planning and Licensing
1991 - 1992
New Product Marketing Manager, Immunology Research Supervisor
1982 - 1991
Marketing and development of Pharmaceuticals and diagnostics
Education
Postdoctoral Fellow
1990 - 1992